Sandra Gurrola - Jun 21, 2022 Form 4 Insider Report for Brooklyn ImmunoTherapeutics, Inc. (ERNA)

Role
Vice President of Finance
Signature
/s/ Sandra Gurrola
Stock symbol
ERNA
Transactions as of
Jun 21, 2022
Transactions value $
-$1,709
Form type
4
Date filed
6/23/2022, 08:31 PM
Previous filing
Mar 17, 2022
Next filing
Jun 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ERNA Common Stock Options Exercise +8.75K +106.67% 17K Jun 21, 2022 Direct F1
transaction ERNA Common Stock Tax liability -$1.71K -3.59K -21.15% $0.48* 13.4K Jun 21, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERNA Restricted Stock Units Options Exercise $0 -8.75K -25% $0.00 26.3K Jun 21, 2022 Common Stock 8.75K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit converts into one share of common stock.
F2 On June 21, 2021, the reporting person was granted 35,000 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.